ImageQuant™ 800 for lateral flow assay development using dyes across the spectrum

The development of assays based on lateral flow has led to low cost and effective large-scale screening of infectious diseases with high specificity. Lateral flow assays consist of membranes, antibodies, and reagents for the detection of a color change or fluorescent dye. Lateral flow assays are an area of intense research and have led to highly robust and sensitive products, including a range of Whatman™ diagnostic solutions from Cytiva. In this application note, Cytiva investigate the use of Conjugated Polymer Nanoparticles (CPNs™) Amersham™ ImageQuant™ 800 systems for lateral flow assays and Western Blotting.